Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Sabre and Google develop AI technology for air travel » 08:34
10/22/20
10/22
08:34
10/22/20
08:34
SABR

Sabre

$6.64 /

-0.19 (-2.78%)

, GOOG

Alphabet

$1,594.00 /

+39.09 (+2.51%)

Sabre (SABR) and Google…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SABR Sabre
$6.64 /

-0.19 (-2.78%)

GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

SABR Sabre
$6.64 /

-0.19 (-2.78%)

09/28/20 Deutsche Bank
Sabre long-term risk/reward looks favorable, says Deutsche Bank
05/11/20 Bernstein
Bernstein upgrades Sabre to Outperform ahead of air travel returning
05/11/20
Sabre upgraded to Outperform from Market Perform at Bernstein
04/13/20 Mizuho
Sabre price target raised to $5 from $3 at Mizuho
GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
10/19/20 Morgan Stanley
ADT Inc. price target lowered to $10 from $17 at Morgan Stanley
SABR Sabre
$6.64 /

-0.19 (-2.78%)

GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

  • 20
    Aug
GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

SABR Sabre
$6.64 /

-0.19 (-2.78%)

GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

SABR Sabre
$6.64 /

-0.19 (-2.78%)

Recommendations
General Motors price target raised to $44 from $36 at JPMorgan » 08:12
10/22/20
10/22
08:12
10/22/20
08:12
GM

General Motors

$35.77 /

+0.185 (+0.52%)

JPMorgan analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

06:41 Today Barclays
General Motors price target raised to $40 from $39 at Barclays
10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
10/20/20 Citi
General Motors price target raised to $57 from $54 at Citi
GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

Hot Stocks
BioCryst announces publication of data from first 24 weeks of APeX-2 trial » 07:26
10/22/20
10/22
07:26
10/22/20
07:26
BCRX

BioCryst

$3.60 /

+0.085 (+2.42%)

BioCryst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

09/30/20 Piper Sandler
Piper says BioCryst's early high dose 9930 data 'impressive'
09/29/20 JPMorgan
BioCryst resumed with an Overweight at JPMorgan
06/26/20 JMP Securities
BioCryst price target raised to $11 from $10 at JMP Securities
06/16/20 BTIG
BioCryst initiated with a Neutral at BTIG
BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

  • 28
    May
  • 14
    Nov
BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

BCRX BioCryst
$3.60 /

+0.085 (+2.42%)

Recommendations
General Motors price target raised to $40 from $39 at Barclays » 06:41
10/22/20
10/22
06:41
10/22/20
06:41
GM

General Motors

$35.77 /

+0.185 (+0.52%)

Barclays analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
10/20/20 Citi
General Motors price target raised to $57 from $54 at Citi
10/19/20 B. Riley Securities
Aspen Aerogels price target raised to $14 from $9 at B. Riley Securities
GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

GM General Motors
$35.77 /

+0.185 (+0.52%)

Hot Stocks
Genetron signs licensing agreement with ImmuQuad Bio for residual cancer assays » 06:20
10/22/20
10/22
06:20
10/22/20
06:20
GTH

Genetron

$11.47 /

+0.27 (+2.41%)

Genetron has entered an…

Genetron has entered an exclusive licensing agreement with Hangzhou ImmuQuad Biotechnologies to develop and commercialize Seq-MRD, a diagnostic assay for the detection and monitoring of minimal residual disease in select hematologic cancers. Under the agreement, Genetron Health has exclusive rights to research, develop, commercialize, and manufacture MRD detection products or testing methods in select hematologic cancers using ImmuQuad's Seq-MRD globally. ImmuQuad is eligible to receive high single-digit royalties on product sales for 10 years following commercialization. Separately, Genetron Health has made a minority equity investment in ImmuQuad. ImmuQuad is a biotechnology company in China focused on developing an immune profiling platform for clinical diagnostics and life sciences research. The company's proprietary immunomics platform employs next-generation sequencing technology to read and decode the diverse genetic code of a patient's adaptive immune system and applies it in key areas, encompassing MRD monitoring for hematologic cancers, early disease detection and cellular therapies discovery and development.

ShowHide Related Items >><<
GTH Genetron
$11.47 /

+0.27 (+2.41%)

GTH Genetron
$11.47 /

+0.27 (+2.41%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$11.47 /

+0.27 (+2.41%)

  • 19
    Jun
GTH Genetron
$11.47 /

+0.27 (+2.41%)

Periodicals
Google technology to be used to aid Trump's border wall, The Intercept reports » 06:09
10/22/20
10/22
06:09
10/22/20
06:09
GOOG

Alphabet

$1,594.00 /

+39.09 (+2.51%)

, GOOGL

Alphabet Class A

$1,586.00 /

+35.03 (+2.26%)

Google to supply AI for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
10/19/20 Morgan Stanley
ADT Inc. price target lowered to $10 from $17 at Morgan Stanley
GOOGL Alphabet Class A
$1,586.00 /

+35.03 (+2.26%)

10/20/20 Credit Suisse
Google Search should see sharper cyclical recovery, says Credit Suisse
GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

GOOGL Alphabet Class A
$1,586.00 /

+35.03 (+2.26%)

GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

GOOG Alphabet
$1,594.00 /

+39.09 (+2.51%)

GOOGL Alphabet Class A
$1,586.00 /

+35.03 (+2.26%)

GOOGL Alphabet Class A
$1,586.00 /

+35.03 (+2.26%)

Conference/Events
American Society of Nephrology to hold virtual annual meeting » 04:55
10/22/20
10/22
04:55
10/22/20
04:55
AKBA

Akebia

$3.30 /

-0.265 (-7.44%)

, ALNY

Alnylam

$136.52 /

-4.93 (-3.49%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

, AMGN

Amgen

$228.86 /

-2.28 (-0.99%)

, AZN

AstraZeneca

$51.56 /

-0.62 (-1.19%)

, BAX

Baxter

$81.87 /

+0.62 (+0.76%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BD

Budget Group

$0.00 /

+ (+0.00%)

, CALT

Calliditas Therapeutics

$27.00 /

-0.57 (-2.07%)

, ICUI

ICU Medical

$192.37 /

+0.44 (+0.23%)

, TCDA

Tricida

$8.81 /

-0.01 (-0.11%)

, SNY

Sanofi

$49.19 /

-0.77 (-1.54%)

, GSK

GlaxoSmithKline

$35.36 /

-0.68 (-1.89%)

, FOLD

Amicus

$17.66 /

+0.69 (+4.07%)

, FMS

Fresenius Medical

$39.80 /

+0.01 (+0.03%)

, DRNA

Dicerna

$19.07 /

-0.12 (-0.63%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, CCXI

ChemoCentryx

$51.99 /

-1.45 (-2.71%)

, KDNY

Chinook Therapeutics

$15.73 /

-1 (-5.98%)

, RTRX

Retrophin

$20.68 /

-0.21 (-1.01%)

, OMER

Omeros

$11.14 /

-0.12 (-1.07%)

, OM

Outset Medical

$45.59 /

-0.79 (-1.70%)

, NVS

Novartis

$84.15 /

-1.6 (-1.87%)

, VRTX

Vertex Pharmaceuticals

$211.36 /

-3.24 (-1.51%)

Kidney Week 2020: Virtual…

Kidney Week 2020: Virtual Annual Meeting will be held on October 19-25. Webcast Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$211.36 /

-3.24 (-1.51%)

TCDA Tricida
$8.81 /

-0.01 (-0.11%)

SNY Sanofi
$49.19 /

-0.77 (-1.54%)

RTRX Retrophin
$20.68 /

-0.21 (-1.01%)

OMER Omeros
$11.14 /

-0.12 (-1.07%)

NVS Novartis
$84.15 /

-1.6 (-1.87%)

KDNY Chinook Therapeutics
$15.73 /

-1 (-5.98%)

ICUI ICU Medical
$192.37 /

+0.44 (+0.23%)

GSK GlaxoSmithKline
$35.36 /

-0.68 (-1.89%)

FOLD Amicus
$17.66 /

+0.69 (+4.07%)

FMS Fresenius Medical
$39.80 /

+0.01 (+0.03%)

DRNA Dicerna
$19.07 /

-0.12 (-0.63%)

CCXI ChemoCentryx
$51.99 /

-1.45 (-2.71%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.87 /

+0.62 (+0.76%)

AZN AstraZeneca
$51.56 /

-0.62 (-1.19%)

AMGN Amgen
$228.86 /

-2.28 (-0.99%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

ALNY Alnylam
$136.52 /

-4.93 (-3.49%)

AKBA Akebia
$3.30 /

-0.265 (-7.44%)

AKBA Akebia
$3.30 /

-0.265 (-7.44%)

09/04/20 RBC Capital
Akebia price target lowered to $5 from $12 at RBC Capital
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
09/04/20 BTIG
Akebia price target lowered to $6 from $26 at BTIG
09/04/20 Mizuho
Akebia price target lowered to $6 from $17 at Mizuho
ALNY Alnylam
$136.52 /

-4.93 (-3.49%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
AMGN Amgen
$228.86 /

-2.28 (-0.99%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
AZN AstraZeneca
$51.56 /

-0.62 (-1.19%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
BAX Baxter
$81.87 /

+0.62 (+0.76%)

10/08/20 Goldman Sachs
Baxter pump delays speak more to FDA protocols than actual product, says Goldman
10/08/20 Piper Sandler
Baxter 510k submission withdrawal 'disappointing,' 'not surprising,' says Piper
10/08/20 KeyBanc
Investors will view Baxter pump news 'somewhat negatively,' says KeyBanc
10/01/20
Fly Intel: Top five analyst upgrades
BAYRY Bayer
$0.00 /

+ (+0.00%)

10/21/20 Morgan Stanley
Bayer price target lowered to EUR 68 from EUR 82 at Morgan Stanley
10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
BD Budget Group
$0.00 /

+ (+0.00%)

CALT Calliditas Therapeutics
$27.00 /

-0.57 (-2.07%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
ICUI ICU Medical
$192.37 /

+0.44 (+0.23%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
03/18/20 KeyBanc
ICU Medical upgraded to Overweight from Sector Weight at KeyBanc
11/12/19 Raymond James
ICU Medical price target raised to $203 from $185 at Raymond James
TCDA Tricida
$8.81 /

-0.01 (-0.11%)

09/29/20 JPMorgan
Tricida resumed with an Underweight at JPMorgan
08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Needham
Tricida price target lowered to $20 from $44 at Needham
08/25/20 Goldman Sachs
Tricida downgraded to Neutral from Buy at Goldman Sachs
SNY Sanofi
$49.19 /

-0.77 (-1.54%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
GSK GlaxoSmithKline
$35.36 /

-0.68 (-1.89%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
FOLD Amicus
$17.66 /

+0.69 (+4.07%)

08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
FMS Fresenius Medical
$39.80 /

+0.01 (+0.03%)

10/13/20 Deutsche Bank
Fresenius Medical price target lowered to EUR 97 from EUR 100 at Deutsche Bank
08/18/20 Morgan Stanley
Fresenius Medical price target raised to EUR 76 from EUR 70 at Morgan Stanley
08/05/20 Jefferies
Fresenius Medical downgraded to Hold from Buy at Jefferies
07/28/20 Berenberg
Fresenius Medical price target raised to EUR 94.85 from EUR 88.25 at Berenberg
DRNA Dicerna
$19.07 /

-0.12 (-0.63%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

CCXI ChemoCentryx
$51.99 /

-1.45 (-2.71%)

09/17/20 H.C. Wainwright
ChemoCentryx price target raised to $85 from $73 at H.C. Wainwright
09/17/20 Piper Sandler
ChemoCentryx target lowered to $67 at Piper Sandler on lower avacopan AAV sales
08/12/20 SVB Leerink
ChemoCentryx price target raised to $75 from $65 at SVB Leerink
07/09/20 Piper Sandler
ChemoCentryx submits NDA for avacopan in AAV to FDA, says Piper Sandler
KDNY Chinook Therapeutics
$15.73 /

-1 (-5.98%)

10/20/20 Oppenheimer
Chinook Therapeutics upgraded to Outperform from Perform at Oppenheimer
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
RTRX Retrophin
$20.68 /

-0.21 (-1.01%)

09/17/20 Wedbush
Wedbush starts Retrophin at Outperform ahead of 'value-creating catalysts'
09/17/20 Wedbush
Retrophin initiated with an Outperform at Wedbush
08/24/20 BofA
Retrophin initiated with a Buy at BofA
07/13/20 BMO Capital
Retrophin price target lowered to $31 from $34 at BMO Capital
OMER Omeros
$11.14 /

-0.12 (-1.07%)

10/20/20 BofA
Omeros initiated with a Buy at BofA
10/20/20 BofA
Omeros initiated with a Buy at BofA
09/01/20 Wedbush
Omeros price target lowered to $12 from $17 at Wedbush
08/21/20 H.C. Wainwright
Omeros price target lowered to $32 from $34 at H.C. Wainwright
OM Outset Medical
$45.59 /

-0.79 (-1.70%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
NVS Novartis
$84.15 /

-1.6 (-1.87%)

09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
VRTX Vertex Pharmaceuticals
$211.36 /

-3.24 (-1.51%)

10/15/20 Truist
Vertex Pharmaceuticals price target lowered to $305 from $330 at Truist
10/15/20 Morgan Stanley
VX-814 discontinuation can drive Vertex shares 5%-10% lower, says Morgan Stanley
10/15/20 JPMorgan
Vertex pipeline setback a 'major disappointment,' says JPMorgan
10/15/20 Citi
Vertex selloff on VX-814 news a buying opportunity, says Citi
VRTX Vertex Pharmaceuticals
$211.36 /

-3.24 (-1.51%)

TCDA Tricida
$8.81 /

-0.01 (-0.11%)

SNY Sanofi
$49.19 /

-0.77 (-1.54%)

RTRX Retrophin
$20.68 /

-0.21 (-1.01%)

OMER Omeros
$11.14 /

-0.12 (-1.07%)

NVS Novartis
$84.15 /

-1.6 (-1.87%)

ICUI ICU Medical
$192.37 /

+0.44 (+0.23%)

GSK GlaxoSmithKline
$35.36 /

-0.68 (-1.89%)

FOLD Amicus
$17.66 /

+0.69 (+4.07%)

DRNA Dicerna
$19.07 /

-0.12 (-0.63%)

CCXI ChemoCentryx
$51.99 /

-1.45 (-2.71%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.87 /

+0.62 (+0.76%)

AZN AstraZeneca
$51.56 /

-0.62 (-1.19%)

AMGN Amgen
$228.86 /

-2.28 (-0.99%)

ALNY Alnylam
$136.52 /

-4.93 (-3.49%)

AKBA Akebia
$3.30 /

-0.265 (-7.44%)

  • 15
    Sep
  • 12
    Aug
  • 11
    Jun
  • 09
    Jun
  • 05
    Jun
  • 12
    May
  • 05
    Dec
SNY Sanofi
$49.19 /

-0.77 (-1.54%)

NVS Novartis
$84.15 /

-1.6 (-1.87%)

GSK GlaxoSmithKline
$35.36 /

-0.68 (-1.89%)

FOLD Amicus
$17.66 /

+0.69 (+4.07%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$51.56 /

-0.62 (-1.19%)

AMGN Amgen
$228.86 /

-2.28 (-0.99%)

AKBA Akebia
$3.30 /

-0.265 (-7.44%)

VRTX Vertex Pharmaceuticals
$211.36 /

-3.24 (-1.51%)

TCDA Tricida
$8.81 /

-0.01 (-0.11%)

SNY Sanofi
$49.19 /

-0.77 (-1.54%)

OMER Omeros
$11.14 /

-0.12 (-1.07%)

OM Outset Medical
$45.59 /

-0.79 (-1.70%)

NVS Novartis
$84.15 /

-1.6 (-1.87%)

GSK GlaxoSmithKline
$35.36 /

-0.68 (-1.89%)

CCXI ChemoCentryx
$51.99 /

-1.45 (-2.71%)

CALT Calliditas Therapeutics
$27.00 /

-0.57 (-2.07%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.87 /

+0.62 (+0.76%)

AZN AstraZeneca
$51.56 /

-0.62 (-1.19%)

AMGN Amgen
$228.86 /

-2.28 (-0.99%)

ALNY Alnylam
$136.52 /

-4.93 (-3.49%)

AKBA Akebia
$3.30 /

-0.265 (-7.44%)

VRTX Vertex Pharmaceuticals
$211.36 /

-3.24 (-1.51%)

SNY Sanofi
$49.19 /

-0.77 (-1.54%)

KDNY Chinook Therapeutics
$15.73 /

-1 (-5.98%)

GSK GlaxoSmithKline
$35.36 /

-0.68 (-1.89%)

AZN AstraZeneca
$51.56 /

-0.62 (-1.19%)

AMGN Amgen
$228.86 /

-2.28 (-0.99%)

AKBA Akebia
$3.30 /

-0.265 (-7.44%)

Yesterday
Periodicals
Katzenberg's streaming service Quibi may shut down, WSJ says » 15:46
10/21/20
10/21
15:46
10/21/20
15:46
DIS

Disney

$127.12 /

+2.05 (+1.64%)

, CMCSA

Comcast

$44.78 /

+0.51 (+1.15%)

, T

AT&T

$26.81 /

+0.04 (+0.15%)

, NFLX

Netflix

$491.34 /

-34.17 (-6.50%)

, AMZN

Amazon.com

$3,207.99 /

-9.82 (-0.31%)

, ROKU

Roku

$223.18 /

+4.78 (+2.19%)

, GOOG

Alphabet

$1,607.80 /

+52.89 (+3.40%)

Jeffrey Katzenberg's…

Jeffrey Katzenberg's mobile streaming service Quibi may be shutting down, wrote the Wall Street Journal's Benjamin Mullin. The service has been plagued by issues almost since inception, including the fact that the coronavirus pandemic sent people home and to streaming services that were suited for larger screen viewing, noted the WSJ story. Katzenberg and CEO Meg Whitman "raised about $1.75B" from the likes of Walt Disney (DIS) NBCUniversal (CMCSA) and AT&T's (T) WarnerMedia for the mobile streaming service, added the story. Other companies in the streaming media space include Netflix (NFLX), Amazon (AMZN), Roku (ROKU), Google (GOOG). Reference Link

ShowHide Related Items >><<
T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

10/20/20 Morgan Stanley
Charter price target raised to $750 from $700 at Morgan Stanley
10/16/20 Citi
Comcast price target raised to $52 from $49 at Citi
10/16/20 Barclays
Comcast price target raised to $48 from $46 at Barclays
10/16/20 Morgan Stanley
Comcast price target raised to $57 from $49 at Morgan Stanley
T AT&T
$26.81 /

+0.04 (+0.15%)

10/19/20 Wolfe Research
AT&T initiated with a Peer Perform at Wolfe Research
10/14/20 Jefferies
Apple price target raised to $140 from $135 at Jefferies
10/05/20
Fly Intel: Top five analyst downgrades
10/05/20 KeyBanc
AT&T downgraded to Underweight from Sector Weight at KeyBanc
NFLX Netflix
$491.34 /

-34.17 (-6.50%)

10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
10/21/20 Canaccord
Netflix profits outperformed while subscriber growth slowed, says Canaccord
AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
10/15/20 Truist
Truist says indications show Amazon Prime Day again a 'record sales period'
ROKU Roku
$223.18 /

+4.78 (+2.19%)

10/15/20
Fly Intel: Top five analyst downgrades
10/15/20 KeyBanc
KeyBanc downgrades Roku with positive fundamentals priced in
10/15/20 KeyBanc
Roku downgraded to Sector Weight from Overweight at KeyBanc
10/08/20 Citi
Citi calls Roku Channel on Fire TV news 'an extraordinary development'
GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
10/19/20 Morgan Stanley
ADT Inc. price target lowered to $10 from $17 at Morgan Stanley
T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

  • 17
    Mar
T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

GOOG Alphabet
$1,607.80 /

+52.89 (+3.40%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

T AT&T
$26.81 /

+0.04 (+0.15%)

ROKU Roku
$223.18 /

+4.78 (+2.19%)

NFLX Netflix
$491.34 /

-34.17 (-6.50%)

DIS Disney
$127.12 /

+2.05 (+1.64%)

CMCSA Comcast
$44.78 /

+0.51 (+1.15%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

AMZN Amazon.com
$3,207.99 /

-9.82 (-0.31%)

Hot Stocks
Cruise, GM seek NHTSA approval for Origin deployment » 14:40
10/21/20
10/21
14:40
10/21/20
14:40
GM

General Motors

$35.68 /

+0.095 (+0.27%)

Self-driving car company…

Self-driving car company Cruise said in a blog post that it and majority shareholder General Motors are "going all in" on its goal to get its self-driving Origin electric vehicle onto roads. Because the Origin does not have driver controls like a traditional car, in the coming months GM and Cruise will be filing an exemption petition with the National Highway Traffic Safety Administration seeking regulatory approval for its deployment. Accordingly, the companies will be withdrawing an earlier exemption petition that was limited to Cruise AVs derived from the Chevrolet Bolt platform. Reference Link

ShowHide Related Items >><<
GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
10/20/20 Citi
General Motors price target raised to $57 from $54 at Citi
10/19/20 B. Riley Securities
Aspen Aerogels price target raised to $14 from $9 at B. Riley Securities
GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

GM General Motors
$35.68 /

+0.095 (+0.27%)

Periodicals
Reservations for first GMC Hummer EV sold out in 10 minutes, BI says » 12:31
10/21/20
10/21
12:31
10/21/20
12:31
GM

General Motors

$35.28 /

-0.305 (-0.86%)

Reservations for the…

Reservations for the "Edition 1" model of the new GMC Hummer electric vehicles were taken just minutes after the vehicle debuted on Tuesday evening, Business Insider's Tim Levin reports. The 2022 Hummer EV Edition 1 is the only trim level GMC will make during the pickup's first year of production, with deliveries starting in fall of next year, Levin notes. All reservations for the vehicle sold out within just 10 minutes of availability, Levin says, citing a General Motors spokesperson. Reference Link

ShowHide Related Items >><<
GM General Motors
$35.28 /

-0.305 (-0.86%)

GM General Motors
$35.28 /

-0.305 (-0.86%)

10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
10/20/20 Citi
General Motors price target raised to $57 from $54 at Citi
10/19/20 B. Riley Securities
Aspen Aerogels price target raised to $14 from $9 at B. Riley Securities
GM General Motors
$35.28 /

-0.305 (-0.86%)

GM General Motors
$35.28 /

-0.305 (-0.86%)

GM General Motors
$35.28 /

-0.305 (-0.86%)

GM General Motors
$35.28 /

-0.305 (-0.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.